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Abstract To analyze the underlying cellular mechanisms
of adaptation to ischemia-induced apoptosis through short
acidic pretreatment, i.e. acidic preconditioning (APC),
Wistar rat coronary endothelial cells (EC) were exposed for
40 min to acidosis (pH 6.4) followed by a 14 h recovery
period (pH 7.4) and ﬁnally treated for 2 h with simulated in
vitro ischemia (glucose-free anoxia at pH 6.4). APC led to
a transient activation of p38 and Akt kinases, but not of
JNK and ERK1/2 kinases, which was accompanied by
signiﬁcant reduction of the apoptotic cell number, caspase-
12/-3 cleavage and Bcl-xL overexpression. These effects of
APC were completely abolished by prevention of Akt- or
p38-phosphorylation during APC. Furthermore, knock-
down of Bcl-xL by siRNA-transfection also abolished the
anti-apoptotic effect of APC. Therefore, APC leads to
protection of EC against ischemic apoptosis by activation
of Akt and p38 followed by overexpression of Bcl-xL,
which is a key anti-apoptotic mechanism of APC.
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Introduction
Apoptosis of endothelial cells (EC) may be responsible for
acute and chronic coronary artery diseases, e.g. through
endothelial dysfunction [1], atherogenesis [2] or throm-
bosis [3]. Myocardial ischemia has been shown to be an
important trigger of apoptosis [4, 5]. Among several pro-
tection strategies directed against ischemic injury,
ischemic preconditioning, i.e. adaptation to ischemia
through one or more short preceding ischemic episodes,
demonstrated a powerful protective potential against
ischemic cell death [6]. Since pretreatment with ischemia
is clinically not applicable, many attempts have been
undertaken to achieve the protective effect of ischemic
preconditioning either pharmacologically [7] or by pre-
treatment with moderate environmental stress, e.g. hypoxia
[8], glucose deprivation [9] or acidosis [10, 11], which are
components of ischemia.
Previously acidosis was found to be an important
stress factor triggering apoptosis in coronary EC under
ischemic conditions through activation of caspase-12
[12]. Accordingly, short acidic pretreatment, i.e. acidic
preconditioning (APC), can protect EC against ischemic
apoptosis [11]. The underlying initial cellular mechanism
leading to this protection, however, remained unknown.
Several previous reports suggested that acidosis may lead
to activation of MAP-kinases and PI3-Akt-kinases path-
ways [13, 14], which play an essential role in regulation
of apoptosis [15]. To examine whether these kinases may
be responsible for the anti-apoptotic effect of APC was
the aim of the present study. We found that APC-
induced activation of p38- and Akt-kinases leads to
overexpression of Bcl-xL and protection against
apoptosis.
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The investigation conforms to the Guide for the Care and
Use of Laboratory Animals published by the US National
Institutes of Health (NIH Publication No. 85-23, revised
1996).
Cell culture
Coronary EC were isolated from 250 to 300 g male Wistar
rats and maintained in Earle’s minimal essential medium
199 supplemented with 10% fetal calf serum and 10%
newborn calf serum till two passages as previously
described [16]. The purity of the cell culture ([95% EC)
was conﬁrmed by immunochemical staining with anti-
bodies against vWF and by uptake of DiI-ac-LDL as
previously described [17]. Experiments were performed
with monolayers reaching 80–90% conﬂuence and 18 h
prior to experiments serum content in culture medium was
reduced from 20 to 5%.
In vitro simulated ischemia
To simulate ischemic conditions cells were treated with
anoxia in combination with glucose-deprivation and aci-
dosis as described previously [12]. Dishes were incubated
for 2 h at 37C in a gas-tight chamber under continuous
ﬂush with a humidiﬁed gas mixture (95% N2 ? 5% CO2).
Analysis of the buffer pH after 2 h of simulated ischemia
did not reveal any signiﬁcant alteration.
Acidic preconditioning
Before simulated ischemia, cells were exposed to acidosis
in cell culture medium (pH 6.4) for 40 min followed by a
recovery period for 14 h in cell culture medium at pH 7.4.
This protocol of preconditioning with acidosis was chosen
from several preconditioning protocols, i.e. variation in
time of APC (20–40 min) and in time of recovery period
(6–24 h) as well as comparison of single versus repetitive
(2 and 3 periods) acidic pretreatment, since it provides the
maximal protection against ischemic apoptosis. In control
group, similar treatment, i.e. change of medium, was per-
formed at pH 7.4. In some experiments treatment with
inhibitors of p38 kinase (SB203580, Calbiochem) and PI3
kinase (LY294002, Calbiochem) during APC was
performed.
Hoechst-33342 and propidium iodide staining
To distinguish between apoptotic and necrotic cells a
staining of nuclei with Hoechst-33342 and propidium
iodide was applied as described previously [12]. Brieﬂy,
cells were trypsinized, washed with PBS and incubated for
10 min with 1 lg/ml Hoechst-33342 and 5 lg/ml propi-
dium iodide. Stained nuclei were visualized with a
converted ﬂuorescence microscope at a magniﬁcation of
7009 using excitation light at 350 nm for Hoechst-33342
and 540 nm for propidium iodide.
For quantitative assay, a blind analysis of 200–300
nuclei from randomized 4–5 ﬁelds was applied. Cells were
scored as apoptotic, when nuclei stained with Hoechst-
33342 produced unequivocal bright blue ﬂuorescence due
to chromatin condensation [12]. Propidium iodide stained
nuclei with normal nuclear morphology, i.e. without signs
of chromatin condensation, were scored as necrotic. Cells
exhibiting both chromatin alteration and propidium iodide
stained nuclei (i.e. ‘‘late-stage apoptotic cells’’) were
included in the apoptotic population. The number of these
cells did not exceed 5% of all cells.
TUNEL staining
TUNEL staining using the In Situ Cell Death Detection
Kit, TMR red (Roche Diagnostic GmbH, Mannheim) was
performed according to the manufacturer’s instruction.
Samples were analyzed with a Leica TCS SP2 confocal
microscope. Four culture dishes (each 200–300 cells) per
group were used for the quantiﬁcation of TUNEL positive
cells.
Western blot
Primary antibodies were: phospho-ERK1/2, ERK1/2,
phospho-SAPK/JNK, SAPK/JNK phospho-Akt, Akt,
phospho-p38, p38, Bcl-xL and caspase-3 (Cell Signaling),
phospho-p38alpha (Millipore), p38beta (Santa Cruz), actin
(Chemicon International), and caspase-12 (Calbiochem).
Speciﬁc bands were visualized after incubation with per-
oxidase-linked/HRP-labeled secondary antibodies by
chemiluminescence using Super-Signal kit (Thermo Sci-
entiﬁc). For multiple analyses of different proteins, western
blot was performed from the same cell extract. Equivalent
sample loading (60 lg proteins/well) was conﬁrmed by
stripping membranes with the Blot Restore Membrane
Stripping buffer (Thermo Scientiﬁc) followed by treatment
with antibodies against actin. Since the loading control was
similar in all membranes, only one blot was shown in
representative ﬁgures.
siRNA transfection
Knock-down of Bcl-xL was achieved by treatment of EC
with small interfering RNA (siRNA) duplexes, corre-
sponding to separate regions within the rat Bcl-xL RNA
sequence (Accession number NM_001033671, Cat. Nr:
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As a control, non-targeting siRNA duplexes (Cat. Nr:
D-001810-01) were applied. Cells were transfected
according to manufacturer’s instructions. Brieﬂy, cells
were seeded 1 day before transfection in MEM containing
10% fetal bovine serum without antibiotics. Bcl-xL siRNA
or non-targeting siRNA were mixed with oligofectamine
(Invitrogen) in OptiMEM (Gibco BRL) for 15 min at room
temperature and then added to the culture medium at a ﬁnal
concentration of 60 nM. Cells were incubated at 37C for
72 h. Protein expression was determined by Western blot
using a speciﬁc antibody to Bcl-xL, which revealed C90%
reduction of Bcl-xL after 72 h.
Statistical analysis
Data are given as mean ± SEM. The comparison of means
between the groups was performed by one-way analysis of
variance followed by Bonferroni post-hoc test. Statistical
signiﬁcance was accepted when P\0.05.
Results
APC-induced protection is accompanied
by phosphorylation of p38 and Akt kinases
Exposure of EC to simulated ischemia for 2 h led to
cleavage of caspase-3 and a rise of apoptotic cell number
(28.8 ± 1.4, n = 5) (Fig. 1a). Short pretreatment with
acidosis (pH 6.4) in the cell culture medium followed by a
recovery period at pH 7.4, i.e. APC, signiﬁcantly reduced
the apoptosis rate (13.0 ± 1.1, n = 6, P\0.05 vs. ische-
mia alone) and caspase-3 cleavage. To examine whether
this effect is due to activation of Akt or MAP kinases,
phosphorylation of Akt, p38, ERK1/2 and JNK kinases was
analyzed. Acidic treatment in cell culture medium did not
increase the phosphorylation of ERK1/2 and JNK kinases,
whereas the phosphorylation of p38 kinase and Akt kinase
was markedly increased after 10 min of acidic treatment
(Fig. 1b). This effect was transient and nearly disappeared
at the end of acidic pretreatment, i.e. after 40 min (Fig. 1c).
Change of medium pH from 6.4 to 7.4 after 40 min of APC
had no effect on phosphorylation of investigated kinases
(data not shown).
It has been shown that two isoforms of p38 kinase, i.e.
p38-alpha and p38-beta, are expressed in the myocardium
[18]. Therefore, to ﬁnd out which isoform was activated by
APC western blot analysis was performed. A marked
expression of p38-alpha was found in EC (Fig. 1d). APC
signiﬁcantly increased the phosphorylation of p38-alpha.
Surprisingly, no p38-beta expression could be found by
western blot analysis in rat coronary EC, whereas in rat
ventricular cardiomyocytes, used as a positive control, a
marked expression p38-beta was found (Fig. 1e).
Inhibition of p38 and Akt kinases activation abolishes
the anti-apoptotic effect of APC
To ﬁnd out whether activation of p38 and Akt kinases
during APC plays a causal role in the anti-apoptotic effect
of preconditioning, treatment with 3 lmol/l SB203580, a
speciﬁc inhibitor of p38 kinase, or with 10 lmol/l
LY294002, a speciﬁc inhibitor of PI3 kinase, was applied
during APC. These concentrations were used as they
abolished kinases phosphorylation without cross-reaction
on Akt and p38 phosphorylation, respectively (Fig. 2a).
The ﬁnding that treatment with SB203580 prevented
Fig. 1 APC suppressed apoptosis and induced activation of p38 and
Akt kinases. a Number of apoptotic EC (Hoechst-33342 staining) and
western blot analysis of cleaved caspase-3 under control conditions
(no treatment) or after 2 h of simulated ischemia (SI) without or with
APC treatment. Values are mean ± SEM, n = 5–6. *P\0.05 versus
SI. b Western blot analysis of phospho-ERK1/2, phospho-SAPK/
JNK, phospho-p38 and phospho-Akt kinases performed with whole
cell lysates prepared from control EC (Con) or from EC after 10 min
of APC. APC led to a marked increase in phosphorylation of Akt and
p38, but not ERK1/2 or SAPK/JNK kinases. c Western blot analysis
of phospho-p38 and phospho-Akt at different time (10–40 min)
during APC. d Western blot analysis of p38-alpha and phospho-p38-
alpha in control EC (Con) or in EC after 10 min of APC. e Western
blot analysis of p38-beta in control rat cardiomyocytes (CM)o ri n
control rat coronary EC. Note that no p38-beta protein could be
detected in EC. Western blot data are representative of three to ﬁve
independent experiments with similar results
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123acidosis-induced p38 phosphorylation indicates the
involvement of the acidosis-induced autophosphorylation
of p38 kinase [19].
Analysis of apoptotic cell number revealed, that inhi-
bition of p38 or Akt kinases activation during acidic
pretreatment abolished the anti-apoptotic effect of APC,
i.e. reduction of the apoptotic cell number (Hoechst-33342
staining), whereas treatment with inhibitors alone, i.e.
without APC, had no effects on ischemia-induced apopto-
sis. No effect on necrotic cell death could be detected
(Fig. 2b). Similarly, APC alone had no effects on apoptotic
or necrotic cell death during 14 h recovery period in our
model [11].
To substantiate the apoptosis analysis, TUNEL staining
of the nuclei was performed (Fig. 2c). This apoptosis
detection method conﬁrmed our data with Hoechst-33342
staining and demonstrated prevention of the anti-apoptotic
effect of APC by inhibition of p38 and Akt kinases
(Fig. 2d).
It has been shown that exposure of coronary EC to
simulated ischemia leads to apoptosis mainly through
activation of ER dependent pathway, i.e. due to cleavage of
ER-bound caspase-12 [12]. Similarly, in the present study a
cleavage of caspase-12 was found (Fig. 3), which was
attenuated by APC. This effect of APC was p38- and Akt-
dependent, since inhibition of these kinases during acidic
pretreatment abolished the APC-effect on caspase-12
cleavage (Fig. 3).
Acidic preconditioning-induced overexpression
of Bcl-xL is p38- and Akt-dependent
To understand more about the underlying downstream anti-
apoptotic mechanisms induced by p38 and Akt activation,
the expression of Bcl-2 family proteins, i.e. Bax, Bak,
Bcl-xL and Bcl-2, was investigated. Although APC did not
change the expression of Bax, Bak and Bcl-2 (data not
shown), the pronounced over-expression of Bcl-xL was
Fig. 2 Inhibition of p38 or Akt kinases prevented the anti-apoptotic
effect of APC. a Inhibition of p38 kinase with SB203580 (SB) or PI3
kinase with LY294002 (LY) during APC abolished the APC-induced
phosphorylation of p38 and Akt kinases without signiﬁcant cross-
effect on Akt and p38 kinases, respectively. Data are representative of
three independent experiments with similar results. b Number of
apoptotic (Hoechst-33342 staining) andnecrotic EC (propidium iodide
staining) under control conditions (no treatment) or after 2 h of
simulated ischemia (SI) without or with APC treatment. Inhibition of
p38 kinase with 3 lmol/l SB203580 (SB) or PI3 kinase with 10 lmol/l
LY294002 (LY) during APC abolished the anti-apoptotic effect
of APC. Values are mean ± SEM, n = 6–8. *P\0.05 versus SI.
c Representative images of the TUNEL-staining in control EC or in
EC after 2 h of simulated ischemia (SI) without or with APC
treatment. F-actin was stained with speciﬁc antibodies (green) and
nuclei were stained DAPI (blue). Arrows show nuclei of apoptotic
cells. d Statistical analysis of the number of TUNEL-positive
apoptotic EC. Similar conditions as in b. Values are mean ± SEM,
n = 4. *P\0.05 versus SI
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123detected by western blot analysis (Fig. 4a). The APC-
induced Bcl-xL overexpression was p38- and Akt-depen-
dent, since inhibition of p38 or Akt kinases during APC
prevented Bcl-xL overexpression (Fig. 4a).
To prove whether the Akt- and p38-dependent overex-
pression of Bcl-xL might be a key mechanism in the
APC-induced protection against ischemic apoptosis,
knock-down of Bcl-xL was performed before simulated
ischemia by treatment of EC with Bcl-xL targeting siRNA.
After 72 h treatment the reduction of Bcl-xL by about 90%
was found (Fig. 4b). Under siRNA pre-treatment, no rise of
Bcl-xL expression could be detected after APC (Fig. 4c).
Subsequent analysis of apoptosis revealed that the Bcl-xL
knock-down abolished the anti-apoptotic effect of APC
(Fig. 4d).
Discussion
The aim of the present study was to ﬁnd out which sig-
naling mechanisms participate in the anti-apoptotic effect
of APC. The main ﬁndings are the following: (1) The anti-
apoptotic effect of APC was associated with transient
phosphorylations of p38 and Akt kinases during acidic
pretreatment followed by overexpression of Bcl-xL. (2)
Prevention of the phosphorylation of these kinases during
APC abolished the APC-induced overexpression of Bcl-xL
and the anti-apoptotic effect of APC.
In the present study we used the model of simulated in
vitro ischemia, i.e. combination of glucose-free anoxia with
extracellular acidosis (pH 6.4), which was characterized
previously in details for endothelial cells and cardiomyo-
cytes [11, 20, 21]. Such an extent of extracellular
acidiﬁcation is comparable to an in vivo myocardial
ischemia, where extracellular pH can drop to as low as 6.0
[22]. It has been shown that acidiﬁcation is an initial trigger
for the cleavage and activation of the endoplasmic reticu-
lum-bound caspase-12 and subsequent apoptosis of
coronary EC under simulated ischemia [12]. Several
reports from other groups conﬁrmed a pro-apoptotic
potential of severe acidosis in vitro and in vivo [23–25].
Thus, acidosis seems to be an important stress factor
leading to apoptosis under ischemic environment.
According to the preconditioning paradigm, ‘‘almost any
stress factor that is potentially harmful for cells can elicit a
preconditioned state, i.e. increased resistance to the dam-
aging stress, when applied in small quantities’’ [6]. Indeed,
protective effect of APC was demonstrated in cell culture
[11] and in the whole heart [10]. However, the underlying
cellular mechanisms of this protection, speciﬁcally against
ischemic apoptosis, were poorly understood. In the present
study the phosphorylation of several MAP kinases and Akt
kinase was investigated, since these kinases (1) can be
activated by extra- or intracellular acidiﬁcation [13, 14, 26]
and (2) may modulate the processing of apoptosis [15]. The
kinase-pattern activated by acidosis is dependent on the
cell type. Indeed, a similar degree of acidosis (pH 6.5–6.6)
Fig. 3 Western blot analysis of cleaved caspase-12 prepared from
extracts of control EC (Con) or EC exposed to simulated ischemia
(SI) without or with APC treatment. Note that treatment with 3 lmol/l
SB203580 (SB) or with 10 lmol/l LY294002 (LY) during APC
abolished the inhibitory effect of APC on caspase-12 cleavage during
SI. Data are representative of three independent experiments with
similar results
Fig. 4 Importance of Bcl-xL overexpression in protective mecha-
nism of APC. a Western blot analysis of Bcl-xL prepared from
extracts of control EC (Con) or EC after 40 min APC followed by
14 h recovery period (APC). Note that treatment with SB203580 (SB)
or LY294002 (LY) abolished the APC-induced overexpression of Bcl-
xL. Data are representative of three independent experiments with
similar results. b Western blot analysis of Bcl-xL prepared from
extracts of control EC (Con) or EC after treatment with Bcl-xL
targeting siRNA (siRNA, 60 nmol/l, 72 h). Data are representative of
three independent experiments with similar results. c Western blot
analysis of Bcl-xL in EC pre-treated with Bcl-xL targeting siRNA
followed by APC (siRNA ? APC) or no treatment (siRNA). Data are
representative of three independent experiments with similar results.
d Effect of pre-treatment for 72 h with targeting siRNA (siRNA) and
acidic preconditioning (APC) on the number of apoptotic EC after 2 h
of simulated ischemia (SI).Values are mean ± SEM, n = 4–5. Note
that no reduction of the apoptotic cell number by APC could be
detected after Bcl-xL knock-down
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[27], whereas it induces activation of PI3 kinase in human
neutrophils [14] or ERK1/2 kinase in human glioblastoma
cells [13]. In the present study, applying coronary endo-
thelial cells, a signiﬁcant increase in phosphorylation of
Akt and p38 kinases, but not ERK1/2 or SAPK/JNK
kinases, during acidic treatment was found. The activation
of these kinases seems to be an initial mechanism in the
anti-apoptotic effect of APC, since inhibition of Akt and
p38 activation during APC completely abolished the APC-
induced protection against ischemic apoptosis.
In agreement with these ﬁndings, several studies dem-
onstrated the involvement of both p38 and Akt kinases in
the protection against apoptosis induced by various proto-
cols of preconditioning [27–29]. The cellular mechanisms
of the anti-apoptotic action of Akt and p38 are complex. In
the present study we found that the overexpression of Bcl-
xL is an important link between Akt-/p38-activation and
the protection against apoptosis. In agreement with this
ﬁnding, the regulation of Bcl-xL expression by Akt and
p38 kinases has been previously shown [30, 31]. The
transcriptional regulation of the bcl-xl gene involves par-
ticipation of several transcriptional factors, e.g. STATs,
Rel/NF-kB, Ets and AP-1 [32]. Since Akt and p38 kinases
are potential up-stream kinases regulating these transcrip-
tional factors, it can be suggested that the acidosis-induced
activation of Akt and p38 kinases leads to a transcriptional
up-regulation of bcl-xl gene. Bcl-xL overexpression seems
to be the key mechanism down-stream of p38 and Akt
kinases responsible for the anti-apoptotic effect of APC,
since Bcl-xL knock-down completely abolished the APC
effect on apoptosis (Fig. 4).
Previously we found that cleavage of the endoplasmic
reticulum-bound caspase-12 represents a main apoptotic
pathway in coronary EC under simulated ischemia [12].
These data and the ﬁnding of the present study that inhi-
bition of Akt and p38 kinases abolished both (1)
overexpression of Bcl-xL and (2) APC-induced suppression
of caspase-12 cleavage argue for Bcl-xL as an essential
mechanism in the suppression of ischemia-induced caspase-
12 cleavage. Indeed, recent reports demonstrated that
overexpression of Bcl-xL prevents endoplasmic reticulum
stress and caspase-12 cleavage [33, 34].
In conclusion, preconditioning of coronary EC with
acidosis leads to activation of Akt and p38 kinases fol-
lowed by overexpression of Bcl-xL and suppression of
caspase-12 cleavage, which is a key mechanism in the
APC-induced protection against ischemic apoptosis. Fur-
ther understanding of the pH-sensing mechanism
responsible for this adaptation phenomenon may lead to the
discovery of new therapeutic approaches for treatment of
diseases accompanied by apoptosis, e.g. tumor, neurode-
generative and ischemic diseases.
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